Über das Unternehmen
- Firmenname (rechtlich): Chengdu Baiyu Pharmaceuticals Co., Ltd
- Internationaler Name: 成都百裕制药股份有限公司 (Chengdu Baiyu Pharmaceutical Co., Ltd.), Chengdu, Sichuan, China
- Marke / Handelsname: Baiyu
- Registrierungsland: China
- Adresse: SichuanChengduChengdu National Cross-Straits Science and Technology Industrial Development Park, Wenjiang District, Chengdu • Sichuan
Beschreibung:
Chengdu Baiyu Pharmaceuticals Co., Ltd, formally established in 2005 (its predecessor began ginkgolide R&D in 2002) and based in the Chengdu National Cross-Straits Science and Technology Industrial Development Park in Wenjiang District, manufactures active pharmaceutical ingredients and finished dosage forms spanning cardiovascular, macrolide and antipyretic/analgesic categories, with ginkgolide as a signature product line. Its ginkgolide injection was approved in 2011, and its ginkgolide dropping pills progressed through Phase I (2017), Phase II (2019) and Phase III (2023) clinical trials; its freeze-dried powder injection workshop passed EU GMP certification in 2022, and in 2024 the company signed an exclusive global licensing agreement with Novartis for a small-molecule drug in development. The company holds 335 China and overseas patent applications (105 granted) and two new-drug certificates, and its ginkgo-related patent won the 18th China Patent Excellence Award. Offering CRO, CSO and CDMO contract services, with roughly 90% domestic and 10% export sales shipped FOB or CIF and settled via L/C or T/T, the company is recognized for its brand, international certification, experienced R&D personnel and broad product line.
Geschäftsaktivitäten
Naturextrakte & Pflanzliche Rohstoffe
Hersteller
Vertrags- & Outsourcing-Dienstleistungen
Auftragsentwicklungs- und Herstellungsorganisation (CDMO)
Pharmazeutische Chemikalien
HerstellerDienstleisterExporteur
Pharmazeutische Wirkstoffe (API)
DienstleisterHerstellerExporteur
Fertigarzneiformen
ExporteurDienstleisterHersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Afghanistan
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Enoxaparin Sodium, Dimethyl Fumarate, Etoricoxib, Apremilast, Brivaracetam, Apixaban, Rivaroxaban, Daprodustat, Ticagrelor, Delafloxacin meglumine, Cangrelor tetrasodium, DOXOFYLLINE, Erythromycin lactobionate, lsavuconazonium, NEOSTIGMINE METHYLSULFATE, Pramipexole., Pyridostigmine bromide, Safenamide mesylate, Tolvaptan, Tolvaptan sodium phosphate
- Vertrags- & Outsourcing-Dienstleistungen: CDMO Services
- Fertigarzneiformen: Finished antibiotic medicines
- Naturextrakte & Pflanzliche Rohstoffe: Ginkgolide injection, Ginkgo terpene lactone dropping pills
- Pharmazeutische Chemikalien: Vismodegib, Dequalinium Chloride, Mianserin Hydrochloride, Cobimetinib, Acoramidis, Nerandomilast
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Parecoxib Sodium, Dobutamine HCL
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
GMP inspection and obtaining the EU GMP certificate
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen